scholarly journals Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen

2006 ◽  
Vol 17 (8) ◽  
pp. 1205-1212 ◽  
Author(s):  
M. Martín ◽  
A. Lluch ◽  
M.A. Seguí ◽  
A. Ruiz ◽  
M. Ramos ◽  
...  
2018 ◽  
Vol 27 (1) ◽  
pp. 123-130 ◽  
Author(s):  
Anu Susanna Toija ◽  
Tarja Helena Kettunen ◽  
Marjut Hannele Kristiina Leidenius ◽  
Tarja Hellin Kaarina Vainiola ◽  
Risto Paavo Antero Roine

Sign in / Sign up

Export Citation Format

Share Document